Innate Immunity - Natural killer cells Prof. Dr. Roland Jacobs Copyright: Wyrwa, Christian. Working group leader Prof. Jacobs We are mainly working on innate immunity and particularly NK cells. These cells [...] building K5. --------------------------------------------------- This working group comprises: Leader: Prof. Dr. Roland Jacobs Co-worker: Sabine Buyny, technician Contact: Rheumatology and Clinical Immunology [...] Immunology OE6830 Hannover Medical School Carl-Neuberg-Str. 1 30625 Hannover Tel.: 0511 532 3581 E-Mail: Prof. Dr. Roland Jacobs
development of new therapeutic strategies. Our working group Head of the working group Prof. Dr. med. Michael Ott Prof. Dr. med. Michael Ott Hannover Medical School OE 6810 Carl-Neuberg-Str. 1 30625 Hannover [...] Prof. Dr. med. Michael Ott / PD Dr. med. Asha Balakrishnan, Ph.D. working group The liver is the focus of our research group's work. Using cell and gene therapy methods, we are developing modern therapeutic [...] laboratory with a view to further therapeutic approaches. In close cooperation with the research group of Prof. Dr. rer. nat. AD Sharma, we are researching new therapeutic procedures for the scarred liver. The
E-health, Serolomics, Modelling, Artificial Intelligence and Implementation Research Project leader: Prof. Dr. Gérard Krause Department / Institute: Helmholtz Centre for Infections Research (HZI) - Dept. [...] ed respiratory epithelial cells to study NRF2 signalling in SARS-CoV-2 infections Project leader: Prof. Dr. Ulrich Martin / Dr. Ruth Olmer Department / Institute: HTTG / LEBAO So far, mainly immortalized [...] auscultation system for differential diagnosis of lung diseases utilizing machine learning Projekt lead: Prof. Dr. Jessica Rademacher Department / Institute: Department of Respiratory Medicine and Infectious
have thus opened the door to a new type of pioneering patient care," explains ENT clinic director Prof. Prof. h.c Dr. med. Thomas Lenarz, MD. The clinic at the MHH is the first in the world to produce an
clinical pharmacology will be held on Thursday March 27th 2025 from 14.00 – 14.50 in lecture hall A by Prof. Koos Burggraaf from the Center for Human Drug Research (CHDR) in Leiden, the first academic-led center [...] development” (QBDD) using biomarker-driven development strategies, a term coined by the CHDR founder Prof. Adam Cohen from Leiden University. https://programme.conventus.de/gpts-2025/program/sessions/499
(TSMU) and Sokhumi State University (SSU), with over € 270,000 over 4 years. The project is led by Prof. Ulrich Martin, Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO) and [...] (Management and Controlling Finance HTTG Research). The project represents a successful continuation of Prof. Martin's decades-long commitment to Georgia. With funding from the Federal Ministry for Economic
Institute of Pharmacology Director: Prof. Dr. Roland Seifert
Sarcoma Center f.l. PD Dr. med. Philipp Ivanyi and Prof. Dr. med. Mohamed Omar. Copyright: Ilka Kosmalski/ MHH Medical direction: Prof. Dr. med. Mohamed Omar. Coordinator: PD Dr. med. Philipp Ivanyi Sarcomas
recipient ("personalized graft"). Team Prof. Dr. Reinhard Schwinzer Funding SFB-TRR 127 Teilprojekt A1 Collaborations We are working on the project together with Prof. Constanca Figueiredo (MHH, Dept. of
UK Prof. Michael Regnier , Heart and Muscle Mechanics (HAMM) Lab, University of Washington, Seattle, USA Prof. Christopher Johnson, Department of Chemistry, Mississippi state University, USA Prof. Marco [...] Non-Linear Spectroscopy, Florence, Italy Prof. Alf Månsson, Faculty of Health and Life Sciences, Linnaeus University, Sweden Prof. Pasquale Bianco/Dr. Irene Pertici/ Prof. Vincenzo Lombardi, University of Florence [...] Florence, Florence , Italy Prof. Sean Lal, Faculty of Medicine and Health, University of Sydney, Australia Collaborators in MHH Prof. Georgios Tsiavaliaris, Biophysical Chemistry, Hannover Medical School